0001209191-17-043852.txt : 20170705 0001209191-17-043852.hdr.sgml : 20170705 20170705213206 ACCESSION NUMBER: 0001209191-17-043852 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170630 FILED AS OF DATE: 20170705 DATE AS OF CHANGE: 20170705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-742-3400 MAIL ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SILVERNAIL LAUREN P CENTRAL INDEX KEY: 0001225755 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 17950734 MAIL ADDRESS: STREET 1: 15279 ALTON PARKWAY STREET 2: SUITE #100 CITY: IRVINE STATE: CA ZIP: 92618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-30 0 0001479290 Revance Therapeutics, Inc. RVNC 0001225755 SILVERNAIL LAUREN P C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560 0 1 0 0 CFO, CBO & Secretary Common Stock 2017-06-30 5 J 0 E 604 18.3175 A 60170 D These shares were acquired by Mrs. Silvernail under the Issuer's 2014 Employee Stock Purchase Plan on June 30, 2017 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). /s/ Gordon Ho, Attorney-in-fact 2017-07-05